|
|
Article: Biotech seeking to disrupt how bacteria communicate.(Pico Pharmaceuticals)
- Article from:
- San Diego Business Journal
- Article date:
- April 13, 2009
- Author:
CopyrightCOPYRIGHT 2009 CBJ, L.P. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Pico Pharmaceuticals, a biotech startup with plans to make more potent cancer and anti-infective drugs, is starting off small. A staff of three full-time employees. A modest office in the University Towne Center area.
But it isn't without grand plans.
Pico aims to tackle common problems that have plagued the field of anti-infective drugs for decades, namely the loss of a drug's effectiveness over time. It has also set its sights on developing an oral cancer drug without some of the adverse side effects seen in standard treatments.
CEO Tim Boyd, who helped bring an over-the-counter cold sore treatment to market as head of Austrian biotech ...